Slider-home

Infectious Diseases and Immunity in Global Health Program

The Infectious Diseases and Immunity in Global Health Program is integrating research in infectious diseases, immunity and global health at the Research Institute of the McGill University Health Centre (RI-MUHC) into work groups with a strong translational focus.

The translational topics are (i) diagnostics, (ii) therapeutics and prevention and (iii) epidemiology and health outcomes. A distinguishing feature of the program are cross-disciplinary research teams encompassing basic biomedical, clinical and health outcomes research that jointly work on novel ways to improve patient well-being and population health in focus diseases.

Program initiatives are well integrated with ongoing research efforts of other groups at McGill University, as well as national and international centres and organizations dedicated to infectious and immune-mediated diseases. This provides the organizational framework for cutting edge research at the front lines of the most pressing global disease threats by program scientists.

Latest updates

IDIGH Calendar

<<  <  August 2018  >  >>
 Mo  Tu  We  Th  Fr  Sa  Su 
    1  2  3  4  5
  6  7  8  9101112
13141516171819
20212223242526
2728293031  

Events

4:30pm-6:00pm (1h30)

IDIGH End of Summer Event

12:00pm-1:00pm (1h)

Dr. Patricia Sampaio Tavares Veras

10:00am-6:00pm (8h)

IDIGH Program Symposium 2019

 More events

Latest IDIGH Publications

  1. Lénárt, A., Engler, K., Lessard, D., Toupin, I., Rodríguez, C. & Lebouché, B.
    (2019)
    .
    The involvement of people living with HIV in the development of HIV-specific or inclusive health instruments: a mixed methods review
    .
    AIDS care
    ,
    p
    .
    1-10
    .
  2. Jung, S. & Vinh, D. C.
    (2019)
    .
    Disseminated Pruritic Macules in a Solid Organ Transplant Recipient
    .
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
    ,
    vol
    .
    69
    ,
    p
    .
    897-899
    .
  3. Bamford, N. C., Le Mauff, F., Subramanian, A. S., Yip, P., Millán, C., Zhang, Y., Zacharias, C., Forman, A., Nitz, M., Codée, J. D. C., Usón, I., Sheppard, D. C. & Howell, P. L.
    (2019)
    .
    Ega3 from the fungal pathogen Aspergillus fumigatus is an endo-α-1,4-galactosaminidase that disrupts microbialbiofilms
    .
    The Journal of biological chemistry
  4. Adams, S., Ehrlich, R., Baatjies, R., Dendukuri, N., Wang, Z. & Dheda, K.
    (2019)
    .
    Evaluating Latent Tuberculosis Infection Test Performance Using Latent Class Analysis in a TB and HIV Endemic Setting
    .
    International journal of environmental research and public health
    ,
    vol
    .
    16
  5. Sabri, A., Quistrebert, J., Naji Amrani, H., Abid, A., Zegmout, A., Abderrhamani Ghorfi, I., Souhi, H., Boucaid, A., Benali, A., Abilkassem, R., Kmari, M., Hassani, A., Lahcen, B., Siah, S., Schurr, E., Boisson-Dupuis, S., Casanova, J.-L., Lahlou, A., Laatiris, A., Louzi, L., Ouarssani, A., Bourazza, A., Aouragh, A., Mustapha, B., Messaoudi, N., Agader, A., Cobat, A., Abel, L. & El Baghdadi, J.
    (2019)
    .
    Prevalence and risk factors for latent tuberculosis infection among healthcare workers in Morocco
    .
    PloS one
    ,
    vol
    .
    14
    ,
    p
    .
    e0221081
    .
More publications